35181-24-9 Usage
Uses
Used in Pharmaceutical Development:
2-(4-Bromo-phenyl)-6-methoxy-quinoline-4-carboxylic acid is used as a potential active pharmaceutical ingredient for the development of drugs with antimicrobial, anticancer, or anti-inflammatory properties. Its unique molecular structure may contribute to its effectiveness in treating a range of medical conditions.
Further research and study are necessary to fully understand the potential uses and effects of this chemical compound, as its biological activities and therapeutic potential are not yet fully established.
Check Digit Verification of cas no
The CAS Registry Mumber 35181-24-9 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 3,5,1,8 and 1 respectively; the second part has 2 digits, 2 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 35181-24:
(7*3)+(6*5)+(5*1)+(4*8)+(3*1)+(2*2)+(1*4)=99
99 % 10 = 9
So 35181-24-9 is a valid CAS Registry Number.
InChI:InChI=1/C17H12BrNO3/c1-22-12-6-7-15-13(8-12)14(17(20)21)9-16(19-15)10-2-4-11(18)5-3-10/h2-9H,1H3,(H,20,21)/p-1
35181-24-9Relevant academic research and scientific papers
New quinoline-based heterocycles as anticancer agents targeting Bcl-2
Hamdy, Rania,Elseginy, Samia A.,Ziedan, Noha I.,Jones, Arwyn T.,Westwell, Andrew D.
, (2019/04/05)
The Bcl-2 protein has been studied as an anticancer drug target in recent years, due to its gatekeeper role in resisting programmed cancer cell death (apoptosis), and the design of BH3 domain mimetics has led to the clinical approval of Venetoclax (ABT-19
Synthesis, molecular docking and anti-inflammatory screening of novel quinoline incorporated pyrazole derivatives using the Pfitzinger reaction II
El-Feky, Said A. H.,Abd El-Samii, Zakaria K.,Osman, Nermine A.,Lashine, Jasmine,Kamel, Mohamed A.,Thabet, Hamdy Kh.
, p. 104 - 116 (2015/02/19)
In continuation of our study of novel quinolines with anti-inflammatory activity using the Pfitzinger reaction, several new quinoline derivatives were synthesized and tested for their anti-inflammatory and ulcerogenic effect. A docking study on the COX-2
